MiniMed Group, Inc.(MMEDV)

Medical - Instruments & Supplies · Northridge, CA

$20.000.00 (0.00%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T18:27:31.699Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:27:31.699Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 560,000,000
Total debt: N/A
Cash: N/A
TTM operating EBITDA: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MMEDV EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

MMEDV Competitors' EV/EBITDA Ratio

MMEDV

MiniMed Group, Inc.

Current

Market Cap

$560.00M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs MMEDV

Market Cap

$561.22M

EV/EBITDA Ratio

N/A

TTM Avg

13.55x

3Y Avg

10.69x

5Y Avg

10.69x

CRMD

CorMedix Inc.

vs MMEDV

Market Cap

$568.28M

EV/EBITDA Ratio

1.81x

TTM Avg

5.90x

3Y Avg

15.41x

5Y Avg

15.41x

MNPR

Monopar Therapeutics Inc.

vs MMEDV

Market Cap

$547.38M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs MMEDV

Market Cap

$576.52M

EV/EBITDA Ratio

N/A

TTM Avg

42.12x

3Y Avg

42.12x

5Y Avg

42.12x

STTK

Shattuck Labs, Inc.

vs MMEDV

Market Cap

$541.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KIDS

OrthoPediatrics Corp.

vs MMEDV

Market Cap

$582.61M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PROK

ProKidney Corp.

vs MMEDV

Market Cap

$536.32M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FLGT

Fulgent Genetics, Inc.

vs MMEDV

Market Cap

$584.34M

EV/EBITDA Ratio

N/A

TTM Avg

2.62x

3Y Avg

44.68x

5Y Avg

68.34x

DCTH

Delcath Systems, Inc.

vs MMEDV

Market Cap

$536.29M

EV/EBITDA Ratio

N/A

TTM Avg

144.36x

3Y Avg

144.36x

5Y Avg

144.36x

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
MiniMed Group, Inc. (MMEDV)	$560.00M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$561.22M	N/A	13.55x	10.69x	10.69x
CorMedix Inc. (CRMD)vs ›	$568.28M	1.81x	5.90x	15.41x	15.41x
Monopar Therapeutics Inc. (MNPR)vs ›	$547.38M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$576.52M	N/A	42.12x	42.12x	42.12x
Shattuck Labs, Inc. (STTK)vs ›	$541.32M	N/A	N/A	N/A	N/A
OrthoPediatrics Corp. (KIDS)vs ›	$582.61M	N/A	N/A	N/A	N/A
ProKidney Corp. (PROK)vs ›	$536.32M	N/A	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$584.34M	N/A	2.62x	44.68x	68.34x
Delcath Systems, Inc. (DCTH)vs ›	$536.29M	N/A	144.36x	144.36x	144.36x

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics